Results of the randomized phase II portion of NRG Oncology/RTOG 0848 evaluating the addition of erlotinib to adjuvant gemcitabine for patients with resected pancreatic head adenocarcinoma.
暂无分享，去创建一个
R. Abrams | B. Fisher | P. Philip | K. Goodman | B. Corn | W. Regine | M. Gillin | T. Dipetrillo | A. Lowy | A. Berger | C. Crane | A. Wu | A. Katz | K. Winter | M. Haddock | H. Safran | S. Seaward | Yixing Jiang | S. Mehta | Suisui Song